Brawn Biotech

Brawn_Biotech26 Apr 2024

Trading

₹

+1.07 (+4.99%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Brawn Biotech

Brawn Biotech

Trading

Brawn_Biotech26 Apr 2024

₹

+1.07 (+4.99%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
29-May-2018	D	Brawn Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2018, inter alia, has recommended a final dividend of Rs. 1/- per equity share having face value of Rs. 10/- each for the year ended March 31, 2018 subject to approval of the shareholders at the ensuing Annual General Meeting of the Company.	12-Sep-2018
30-May-2017	D	Brawn Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2017, inter alia, has recommended a final dividend of Rs. 1.5/- per equity share of face value of Rs. 10/- each for the year ended March 31, 2017 subject to approval of shareholders in the Annual General Meeting of the Company.	14-Sep-2017
08-Feb-2024	BC	BRAWN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve And take on record the Unaudited Financial R	14-Feb-2024
03-Nov-2023	BC	BRAWN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve And take on record the Unaudited Financial R	10-Nov-2023
23-Aug-2023	BC	The Board of the Company at it's meeting held on 23rd August, 2023, inter-alia has considered and transacted the following businesses: 1. Considered and approved the Boards' Report and Management Dis	25-Sep-2023
05-Sep-2023	BC	Annual General Meeting	18-Sep-2023
02-Aug-2023	BC	BRAWN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 inter alia to consider and approve Unaudited Standalone Financial Results for t	09-Aug-2023

No Rights has been declared by Brawn_Biotech

Book Closure

Record Date	Split Date	Purpose
14-Feb-2024	-	BRAWN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve And take on record the Unaudited Financial R
10-Nov-2023	-	BRAWN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve And take on record the Unaudited Financial R
25-Sep-2023	-	The Board of the Company at it's meeting held on 23rd August, 2023, inter-alia has considered and transacted the following businesses: 1. Considered and approved the Boards' Report and Management Dis
18-Sep-2023	01 Jan'1900	Annual General Meeting
09-Aug-2023	-	BRAWN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 inter alia to consider and approve Unaudited Standalone Financial Results for t

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Brawn Biotech Ltd ₹22.53(+1.07/4.99%)	22.53	+1.07	6.76	28.01	0.00	1.18
Computer Point Ltd ₹4.70(+0.09/1.95%)	4.70	+0.09	14.10	141.03	470.00	0.42
Ambalal Sarabhai Enterprises Ltd ₹46.82(-1.20/-2.50%)	46.82	-1.20	358.80	117.36	0.00	9.86
Novartis India Ltd ₹1,055.10(+9.20/0.88%)	1,055.10	+9.20	2,605.13	81.60	27.27	3.71
Mysore Petro Chemicals Ltd ₹183.05(-1.05/-0.57%)	183.05	-1.05	120.51	65.66	16.14	1.18
Aegis Logistics Ltd ₹635.95(+35.60/5.93%)	635.95	+35.60	22,321.85	61.80	50.59	10.06

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	2.84	2.92	7.29	0.12	6.31	7.77
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	2.84	2.92	7.29	0.12	6.31	7.77
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.00	0.23	0.00	0.00
Total Income	2.85	2.92	7.29	0.35	6.31	7.77
Total Expenditure	3.43	3.31	7.44	0.08	6.32	8.10
PBIDT	-0.58	-0.39	-0.16	0.27	-0.01	-0.33
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	-0.58	-0.39	-0.16	0.27	-0.01	-0.34
Depreciation	0.03	0.03	0.02	0.00	0.03	0.02
Tax	0.00	0.00	0.00	0.04	0.00	-0.01
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-0.61	-0.42	-0.17	0.23	-0.04	-0.35
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.61	-0.42	-0.17	0.23	-0.04	-0.35

EPS (Unit Curr.)	-2.02	-1.43	-0.58	0.47	-0.18	-1.25
EPS (Adj) (Unit Curr.)	-2.02	-1.43	-0.58	0.47	-0.18	-1.25
Calculated EPS (Unit Curr.)	-2.02	-1.41	-0.57	0.47	-0.12	-1.18
Calculated EPS (Adj) (Unit Curr.)	-2.02	-1.41	-0.57	0.47	-0.12	-1.18
Calculated EPS (Ann.) (Unit Curr.)	-8.10	-5.64	-2.30	1.89	-0.50	-4.72
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-8.10	-5.64	-2.30	1.89	-0.50	-4.72
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	3.00	3.00	3.00	4.90	3.00	3.00
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-20.42	-13.36	-2.19	225.00	-0.16	-4.25
PBDTM(%)	-20.42	-13.36	-2.19	225.00	-0.16	-4.38
PATM(%)	-21.48	-14.38	-2.33	191.67	-0.63	-4.50

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	3.00	3.00	3.00	3.00	3.00	3.00
Reserves Total	3.31	4.22	5.79	6.26	5.66	4.63
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	6.31	7.22	8.79	9.26	8.66	7.63
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	6.31	7.22	8.79	9.26	8.66	7.63
APPLICATION OF FUNDS :
Gross Block	0.77	0.67	0.38	0.38	0.37	0.37
Less : Accumulated Depreciation	0.40	0.29	0.24	0.20	0.18	0.15
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.37	0.38	0.14	0.18	0.19	0.22
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	4.79	4.72	0.26	0.39	0.34	0.35
Sundry Debtors	5.32	2.81	9.28	15.00	16.46	15.05
Cash and Bank	0.44	0.22	0.40	0.40	0.54	0.40
Loans and Advances	2.85	4.43	2.79	3.42	4.41	5.96
Total Current Assets	13.40	12.19	12.73	19.21	21.75	21.76
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	7.97	5.54	4.11	10.06	11.99	13.19
Provisions	0.08	0.78	0.79	0.86	1.71	1.55
Total Current Liabilities	8.05	6.32	4.90	10.92	13.70	14.74
Net Current Assets	5.35	5.87	7.82	8.29	8.05	7.02
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.16	0.62	0.15	0.07	0.07	0.09
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.01	0.01
Net Deferred Tax	0.16	0.62	0.15	0.07	0.06	0.08
Total Assets	5.88	6.88	8.11	8.54	8.30	7.32
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.22	0.40	0.40	0.54	0.40
Net Cash from Operating Activities	0.32	0.19	0.03	-0.08	0.21
Net Cash Used In Investing Activities	-0.10	-0.30	0.00	-0.02	0.00
Net Cash Used In Financing Activities	-0.01	-0.06	-0.04	-0.05	-0.06
Net Inc./Dec In Cash And Cash Equivalents	0.21	-0.17	0.00	-0.14	0.15
Cash And Cash Equivalents At End Of The Year	0.44	0.22	0.40	0.40	0.54

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

53.64%

FII Shareholding

0.00%

DII Shareholding

0.35%

Public Shareholding

46.01%

**Promoter pledged shareholding 53.64%

About Brawn Biotech Ltd

Brawn Biotech Ltd is in the Trading sector, having a market capitalization of Rs. 6.76 crores. It has reported a sales of Rs. 2.84 crores and a net profit of Rs. -0.61 crores for the quarter ended December 2018. The company management includes , Brij Bala Gupta.,Kanta Takkar,Subhash Chander,Priyanka Sharma (Brawn Biotech Ltd) among others.

Chairman

Registered office

C-64 Lajpat Nagar-1 1st Floor,,New Delhi,New Delhi,110024

FAX :

Background

Incorporation Year1985

Face Value₹10

Market Lot1

How to buy Brawn Biotech shares on nse?

To buy Brawn Biotech shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Brawn Biotech share price today?

The Brawn Biotech shares price on nse is Rs.22.53 today.

What is the market cap of Brawn Biotech shares on BSE ?

The company has a market capitalization of Rs.6.76Cr

What is the PE & PB ratio of Brawn Biotech shares ?

PE is 0 and PB is 1.18

What is the 52 Week High and Low of Brawn Biotech shares?

Brawn Biotech stock price high: Rs.26.8 Brawn Biotech stock price low: Rs.14.36